Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

12.80
Delayed Data
As of Mar 22
 +0.60 / +4.92%
Today’s Change
6.27
Today|||52-Week Range
13.70
+5.35%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 21.50, with a high estimate of 25.00 and a low estimate of 15.00. The median estimate represents a +67.97% increase from the last price of 12.80.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.61
Sales
$5.9M
Reporting Date
Apr 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -478.13%
 
 
 
 
 
 
Growthannually -730.77%
 
 
 
 
 
 

Sales

Growthquarterly -82.27%
 
 
 
 
 
 
Growthannually -71.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.